Tilo Kunath

Dr. Tilo Kunath, a group leader at the MRC Centre for Regenerative Medicine, discusses his groundbreaking research on clinical-grade stem cells and their application in patient therapies. He explains the critical distinction between clinical-grade and research-grade cells and shares insights on the Gene Modification Protocol for producing compliant lines. Tilo also touches on the implications of genomic variation and emphasizes the importance of safety testing. Plus, don’t miss his amusing anecdote about SEM images that sparked laughter!